Ye Zhishi, Gettys Kristen E, Dai Mingji
Department of Chemistry and Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States.
Beilstein J Org Chem. 2016 Apr 13;12:702-15. doi: 10.3762/bjoc.12.70. eCollection 2016.
Piperazine ranks within the top three most utilized N-heterocyclic moieties in FDA-approved small-molecule pharmaceuticals. Herein we summarize the current synthetic methods available to perform C-H functionalization on piperazines in order to lend structural diversity to this privileged drug scaffold. Multiple approaches such as those involving α-lithiation trapping, transition-metal-catalyzed α-C-H functionalizations, and photoredox catalysis are discussed. We also highlight the difficulties experienced when successful methods for α-C-H functionalization of acyclic amines and saturated mono-nitrogen heterocyclic compounds (such as piperidines and pyrrolidines) were applied to piperazine substrates.
哌嗪在FDA批准的小分子药物中是使用最频繁的三大含氮杂环部分之一。在此,我们总结了目前可用于对哌嗪进行C-H官能化的合成方法,以便为这种有优势的药物骨架赋予结构多样性。讨论了多种方法,如涉及α-锂化捕获、过渡金属催化的α-C-H官能化和光氧化还原催化的方法。我们还强调了将无环胺和饱和单氮杂环化合物(如哌啶和吡咯烷)的α-C-H官能化成功方法应用于哌嗪底物时所遇到的困难。